{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:49:56Z","timestamp":1791344996870,"version":"4.3.1"},"reference-count":20,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1002\/ajh.23338","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T20:13:34Z","timestamp":1348690414000},"source":"Crossref","is-referenced-by-count":101,"title":["Three novel patient\u2010derived BCR\/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors"],"prefix":"10.1002","volume":"87","author":[{"given":"Sara","family":"Redaelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mologni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rostagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Magistroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ceccon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Viltadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gambacorti\u2010Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"e_1_2_1_3_1_2_2","article-title":"Dasatinib versus imatinib in newly diagnosed chronic\u2010phase chronic myeloid leukemia","author":"Kantarjian H","journal-title":"N Eng J Med"},{"key":"e_1_2_1_3_1_3_2","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","author":"Saglio G","journal-title":"N Eng J Med"},{"key":"e_1_2_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1199"},{"key":"e_1_2_1_3_1_5_2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.38.7522","article-title":"Bosutinib versus imatinib in newly diagnosed chronic\u2010phase chronic myeloid leukemia: Results from the BELA trial","author":"Cortes JE","year":"2012","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.09.028"},{"key":"e_1_2_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"CortesJ TalpazM BixbyD et al. A phase 1 trial of oral ponatinib (AP24534) in patients with refractory chronic myelogenous leukemia (CML) and other hematologic malignancies: Emerging safety and clinical response findings. ASH Annual Meeting Abstracts2010;116:210\u2013.","DOI":"10.1182\/blood.V116.21.210.210"},{"key":"e_1_2_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)00979-3"},{"key":"e_1_2_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70342-X"},{"key":"e_1_2_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2010.01054.x"},{"key":"e_1_2_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR\u2010ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch\u2010control inhibitor DCC\u20102036","volume":"19","author":"Chan Wayne W","year":"2011","journal-title":"Cancer Cell"},{"key":"e_1_2_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8853"},{"key":"e_1_2_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-197715"},{"key":"e_1_2_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004580"},{"key":"e_1_2_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800587105"},{"key":"e_1_2_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.20.1641"},{"key":"e_1_2_1_3_1_17_2","first-page":"625","article-title":"Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients","volume":"9","author":"Gambacorti\u2010Passerini C","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1108"},{"key":"e_1_2_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.leu.2403453","article-title":"Evidence for D276G and L364I Bcr\u2010Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib","volume":"19","author":"Piazza RG","year":"2005","journal-title":"Leukemia"},{"key":"e_1_2_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118820"},{"key":"e_1_2_1_3_1_21_2","article-title":"In vivo eradication of human BCR\/ABL\u2010positive leukemia cells with an ABL kinase inhibitor","author":"le Coutre P","journal-title":"J Natl Cancer Inst"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23338","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:48:15Z","timestamp":1697438895000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1002\/ajh.23338"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23338","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}